Premature discontinuation of clinical trial for reasons not related to efficacy, safety, or feasibility.
about
Characteristics of pivotal trials and FDA review of innovative devices17-Hydroxyprogesterone caproate to prolong pregnancy after preterm rupture of the membranes: early termination of a double-blind, randomized clinical trial.Would tirofiban have been shown non-inferior to abciximab had the TENACITY trial not been terminated for financial reasons?"One teabag is better than four": Participants response to the discontinuation of 2% PRO2000/5 microbicide gel in KwaZulu-Natal, South AfricaElderly patients with myocardial infarction selected for conservative or invasive treatment strategy.Industry and evidence-based medicine: Believable or conflicted? A systematic review of the surgical literature.Stopping trials early for commercial reasons: the risk-benefit relationship as a moral compass.Institutional ethics review of clinical study agreementsEditorial: No-difference Studies Make a Big Difference.Risk of discontinuation of Advanced Therapy Medicinal Products clinical trialsEditorial: JBJS, The Bone & Joint Journal, and Clinical Orthopaedics and Related Research Require Prospective Registration of Randomized Clinical Trials-Why Is This Important?Societal responsibilities of clinical trial sponsors. Lack of commercial pay off is not a legitimate reason for stopping a trial.Primary anastomosis vs nonrestorative resection for perforated diverticulitis with peritonitis: a prematurely terminated randomized controlled trial.Short-term efficacy and safety of extended-release fluvastatin in a large cohort of elderly patients.Discontinued drug therapies to treat diabetes in 2015.Odon device for instrumental vaginal deliveries: results of a medical device pilot clinical study.In defense of the Hopkins Lead Abatement Studies.A duty to participate in research: does social context matter?Responsibilities of sponsors are limited in premature discontinuation of trialsFactors associated with clinical trials that fail and opportunities for improving the likelihood of success: A review
P2860
Q28543199-687382A6-9584-4173-AB91-8EC069042DC2Q34113982-772B465E-E084-405D-A132-612E0F7CB192Q34145163-2A85FFF3-8B36-4877-8171-247EBD8A6AB7Q34510587-6FBA3D3F-7135-4EA8-A2A5-2206B4118DF8Q35024306-3DE894D8-D62F-4F7E-BE83-A585CEEE006DQ35372675-BD68B29A-A1E9-4568-A23D-4D0649BF8AF8Q35430247-3FC356A3-842C-4905-BF37-29EF713C8B4DQ35559637-0AACCBAE-309F-4FD9-B579-5D0F8C1DB923Q36101030-0916EE19-55B9-4DA9-9351-7289471EA8D9Q39444677-0CB2FCFA-9D7A-448C-B5EB-0FF3E1EF574EQ42345835-E7ECBF96-D505-46DF-869E-9FFD751B6BF1Q42771076-D288F89D-6192-4976-B045-4BEBDDF98BB4Q43511454-511E7D85-A5D7-4952-93DF-A8A2866FD32AQ44530977-4B017C30-E709-4FA4-80AD-B78BCF5D2272Q51327624-05D1BB4D-B026-46B9-BCF8-DC45E9BBD63FQ52662215-773BCC0D-9A6B-4FBB-9829-639B4429D64FQ53446348-FBFE4126-3F68-4A67-9302-EE4756711904Q56897213-921444B4-B65B-40B3-BAF7-FB192A70918FQ56906106-56869294-5157-4EE3-A2E4-233967AC0C4DQ58797089-47F57C24-5F80-42A8-BEFE-C5EF87001D41
P2860
Premature discontinuation of clinical trial for reasons not related to efficacy, safety, or feasibility.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Premature discontinuation of c ...... icacy, safety, or feasibility.
@ast
Premature discontinuation of c ...... icacy, safety, or feasibility.
@en
type
label
Premature discontinuation of c ...... icacy, safety, or feasibility.
@ast
Premature discontinuation of c ...... icacy, safety, or feasibility.
@en
prefLabel
Premature discontinuation of c ...... icacy, safety, or feasibility.
@ast
Premature discontinuation of c ...... icacy, safety, or feasibility.
@en
P2093
P2860
P356
P1433
P1476
Premature discontinuation of c ...... icacy, safety, or feasibility.
@en
P2093
Bruckert E
Delahaye F
Leitersdorf E
P2860
P304
P356
10.1136/BMJ.322.7286.603
P407
P577
2001-03-01T00:00:00Z